Sławiński, G.; Wrona, A.; Dąbrowska-Kugacka, A.; Raczak, G.; Lewicka, E.
Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review. Int. J. Mol. Sci. 2020, 21, 7195.
https://doi.org/10.3390/ijms21197195
AMA Style
Sławiński G, Wrona A, Dąbrowska-Kugacka A, Raczak G, Lewicka E.
Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review. International Journal of Molecular Sciences. 2020; 21(19):7195.
https://doi.org/10.3390/ijms21197195
Chicago/Turabian Style
Sławiński, Grzegorz, Anna Wrona, Alicja Dąbrowska-Kugacka, Grzegorz Raczak, and Ewa Lewicka.
2020. "Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review" International Journal of Molecular Sciences 21, no. 19: 7195.
https://doi.org/10.3390/ijms21197195
APA Style
Sławiński, G., Wrona, A., Dąbrowska-Kugacka, A., Raczak, G., & Lewicka, E.
(2020). Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review. International Journal of Molecular Sciences, 21(19), 7195.
https://doi.org/10.3390/ijms21197195